Listen to short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 14.
https://www.oncotarget.com/archive/v12/i14/
Cover Paper - “Esomeprazole enhances the effect of ionizing radiation to improve tumor control” https://doi.org/10.18632/oncotarget.28008
Research Paper - “Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer”
https://doi.org/10.18632/oncotarget.28014
Research Paper - “MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer” https://doi.org/10.18632/oncotarget.28002
Research Paper - “The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma”
https://doi.org/10.18632/oncotarget.28013
Research Paper - “Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia” https://doi.org/10.18632/oncotarget.28000
Research Paper - “Prokineticin-1 induces normal lymphangiogenic activity and is involved in lymphangiogenesis and lymph node metastasis in colorectal cancer” https://doi.org/10.18632/oncotarget.28016
Research Paper - “Appropriate body mass index cutoffs for type 2 diabetes in Xinjiang population: defining the influence of liver aminotransferase” https://doi.org/10.18632/oncotarget.28009
Review - “Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment” https://doi.org/10.18632/oncotarget.28010
Research Perspective - “Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives” https://doi.org/10.18632/oncotarget.27936
Research Perspective - “A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in in vivo xenograft studies” https://doi.org/10.18632/oncotarget.27960
Keywords - mebendazole, pancreatic cancer, esomeprazole, tumor control, MRI, breast cancer, eltrombopag, colorectal cancer, AML, type 2 diabetes, chlorpromazine, immunotherapy, tumors, cancer, science, research, oncology
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/oncotargetyoutube
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget
Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
